Harvard Bioscience, Inc. (HBIO)
NASDAQ · Healthcare
Harvard Bioscience, Inc. EBITDA 2009–2025
Harvard Bioscience, Inc. annual/quarterly ebitda history and growth rate from 2010 to 2012. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Harvard Bioscience, Inc. annual ebitda for 2012 was 12.0 M, a 5.48% decrease from 2011.
- Harvard Bioscience, Inc. annual ebitda for 2011 was 12.7 M, a 9.91% decrease from 2010.
- Harvard Bioscience, Inc. annual ebitda for 2010 was 14.1 M.
No data available.
Harvard Bioscience, Inc. EBITDA — FAQ
Harvard Bioscience, Inc. (HBIO) ebitda over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see HBIO's ebitda history?
The chart and table above show Harvard Bioscience, Inc.'s ebitda by year and by quarter, including the growth rate.